Capital Fund Management (CFM)’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.52M Buy
139,529
+68,243
+96% +$852K 0.01% 1502
2025
Q4
$922K Buy
71,286
+26,514
+59% +$340K ﹤0.01% 2051
2025
Q3
$578K Buy
+44,772
New +$598K ﹤0.01% 2268
2024
Q4
Sell
-27,860
Closed -$590K 2187
2024
Q3
$435K Sell
27,860
-72,829
-72% -$1.32M ﹤0.01% 1870
2024
Q2
$1.72M Buy
100,689
+29,720
+42% +$523K 0.01% 1442
2024
Q1
$1.11M Buy
70,969
+17,058
+32% +$251K ﹤0.01% 1676
2023
Q4
$805K Sell
53,911
-61,470
-53% -$823K ﹤0.01% 1887
2023
Q3
$1.86M Buy
+115,381
New +$3.33M 0.01% 1392
2023
Q2
Sell
-14,175
Closed -$852K 1832
2023
Q1
$852K Buy
+14,175
New +$1.13M ﹤0.01% 1316
2021
Q1
Sell
-24,796
Closed -$4.29M 1514
2020
Q4
$4.29M Buy
+24,796
New +$3.39M 0.04% 519
2020
Q2
Sell
-24,201
Closed -$1.63M 1396
2020
Q1
$1.63M Buy
24,201
+7,270
+43% +$575K 0.03% 587
2019
Q4
$1.43M Buy
+16,931
New +$1.37M 0.01% 967

Other funds holding NVCR